MEDINDIA
English
हिन्दी
Español
français
中文
Email
Acebutolol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Acebutolol.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitroglycerin.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Nitroglycerin.
Aliskiren
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Aliskiren.
Alteplase
The serum concentration of Alteplase can be decreased when it is combined with Nitroglycerin.
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Nitroglycerin.
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Nitroglycerin.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Nitroglycerin.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Nitroglycerin.
Amlodipine
The risk or severity of adverse effects can be increased when Amlodipine is combined with Nitroglycerin.
Amobarbital
Amobarbital may increase the hypotensive activities of Nitroglycerin.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nitroglycerin.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nitroglycerin.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Amyl Nitrite.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Nitroglycerin.
Apraclonidine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Apraclonidine.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Nitroglycerin.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Nitroglycerin.
Atenolol
The risk or severity of adverse effects can be increased when Atenolol is combined with Nitroglycerin.
Avanafil
Avanafil may increase the vasodilatory activities of Nitroglycerin.
Azilsartan
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Nitroglycerin.
Barbital
Barbital may increase the hypotensive activities of Nitroglycerin.
Benazepril
The risk or severity of adverse effects can be increased when Benazepril is combined with Nitroglycerin.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Nitroglycerin.
Bepridil
The risk or severity of adverse effects can be increased when Bepridil is combined with Nitroglycerin.
Betaxolol
The risk or severity of adverse effects can be increased when Betaxolol is combined with Nitroglycerin.
Bisoprolol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nitroglycerin.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Nitroglycerin.
Bretylium
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Bretylium.
Brimonidine
The risk or severity of adverse effects can be increased when Brimonidine is combined with Nitroglycerin.
Bromocriptine
The bioavailability of Bromocriptine can be increased when combined with Nitroglycerin.
Bumetanide
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Nitroglycerin.
Cabergoline
The bioavailability of Cabergoline can be increased when combined with Nitroglycerin.
Canagliflozin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Canagliflozin.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Candesartan cilexetil.
Captopril
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Captopril.
Carteolol
The risk or severity of adverse effects can be increased when Carteolol is combined with Nitroglycerin.
Carvedilol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Carvedilol.
Chlorothiazide
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Chlorothiazide.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Nitroglycerin.
Chlorthalidone
The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Nitroglycerin.
Cilazapril
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Cilazapril.
Clevidipine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Nitroglycerin.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Nitroglycerin.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Nitroglycerin.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Nitroglycerin.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Nitroglycerin.
Dapagliflozin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Dapagliflozin.
Dapsone
The risk or severity of adverse effects can be increased when Dapsone is combined with Nitroglycerin.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Nitroglycerin.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Nitroglycerin.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Diclofenamide.
Dihydroergocornine
The bioavailability of Dihydroergocornine can be increased when combined with Nitroglycerin.
Dihydroergocristine
The bioavailability of Dihydroergocristine can be increased when combined with Nitroglycerin.
Dihydroergotamine
The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.
Diltiazem
The risk or severity of adverse effects can be increased when Diltiazem is combined with Nitroglycerin.
Dinutuximab
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Dinutuximab.
Dipyridamole
Dipyridamole may increase the vasodilatory activities of Nitroglycerin.
Doxazosin
The risk or severity of adverse effects can be increased when Doxazosin is combined with Nitroglycerin.
Duloxetine
Nitroglycerin may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Empagliflozin.
Enalapril
The risk or severity of adverse effects can be increased when Enalapril is combined with Nitroglycerin.
Enalaprilat
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Nitroglycerin.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Nitroglycerin.
Eplerenone
The risk or severity of adverse effects can be increased when Eplerenone is combined with Nitroglycerin.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Nitroglycerin.
Eprosartan
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Eprosartan.
ergoloid mesylates, USP
The bioavailability of Ergoloid mesylate can be increased when combined with Nitroglycerin.
Ergonovine
The bioavailability of Ergonovine can be increased when combined with Nitroglycerin.
Ergotamine
The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Nitroglycerin.
Ethacrynate
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Etacrynic acid.
Ethanol
Ethanol may increase the vasodilatory activities of Nitroglycerin.
Felodipine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Felodipine.
Fenoldopam
The risk or severity of adverse effects can be increased when Fenoldopam is combined with Nitroglycerin.
Fosinopril
The risk or severity of adverse effects can be increased when Fosinopril is combined with Nitroglycerin.
Fostamatinib
Fostamatinib may increase the vasodilatory activities of Nitroglycerin.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Nitroglycerin.
Guanfacine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Guanfacine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Nitroglycerin.
Heparin
Nitroglycerin may decrease the anticoagulant activities of Heparin.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Nitroglycerin.
Hydralazine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Hydralazine.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Hydrochlorothiazide.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Nitroglycerin.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Nitroglycerin.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Nitroglycerin.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Nitroglycerin.
Indapamide
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Indapamide.
Indoramin
The risk or severity of adverse effects can be increased when Indoramin is combined with Nitroglycerin.
Irbesartan
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Irbesartan.
Isocarboxazid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Nitroglycerin.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Nitroglycerin.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Isoxsuprine.
Isradipine
The risk or severity of adverse effects can be increased when Isradipine is combined with Nitroglycerin.
Labetalol
The risk or severity of adverse effects can be increased when Labetalol is combined with Nitroglycerin.
Lacidipine
Nitroglycerin may increase the hypotensive activities of Lacidipine.
Lercanidipine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Nitroglycerin.
Levobunolol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Nitroglycerin.
Levodopa
Nitroglycerin may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Nitroglycerin.
Lisinopril
The risk or severity of adverse effects can be increased when Lisinopril is combined with Nitroglycerin.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Lisinopril is combined with Nitroglycerin.
Lisuride
The bioavailability of Lisuride can be increased when combined with Nitroglycerin.
Lofexidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Nitroglycerin.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Nitroglycerin.
Mannitol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Mannitol.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Nitroglycerin.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Nitroglycerin.
Mepirodipine
The risk or severity of adverse effects can be increased when Barnidipine is combined with Nitroglycerin.
Metergoline
The bioavailability of Metergoline can be increased when combined with Nitroglycerin.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Nitroglycerin.
Methohexital
Methohexital may increase the hypotensive activities of Nitroglycerin.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Nitroglycerin.
Methyldopa
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Methyldopa.
METHYLDOPA ANHYDROUS
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Methyldopa.
Methylergonovine
The bioavailability of Methylergometrine can be increased when combined with Nitroglycerin.
Methysergide
The bioavailability of Methysergide can be increased when combined with Nitroglycerin.
Metipranolol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Metipranolol.
Metolazone
The risk or severity of adverse effects can be increased when Metolazone is combined with Nitroglycerin.
Metoprolol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Nitroglycerin.
Minoxidil
The risk or severity of adverse effects can be increased when Minoxidil is combined with Nitroglycerin.
Moexipril
The risk or severity of adverse effects can be increased when Moexipril is combined with Nitroglycerin.
Molsidomine
Molsidomine may increase the hypotensive activities of Nitroglycerin.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Nitroglycerin.
Moxonidine
The risk or severity of adverse effects can be increased when Moxonidine is combined with Nitroglycerin.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Nitroglycerin.
Nadolol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Nadolol.
Nebivolol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Nebivolol.
Nesiritide
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Nesiritide.
Nicardipine
The risk or severity of adverse effects can be increased when Nicardipine is combined with Nitroglycerin.
Nicergoline
The bioavailability of Nicergoline can be increased when combined with Nitroglycerin.
Nicorandil
Nicorandil may increase the hypotensive activities of Nitroglycerin.
Nifedipine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Nifedipine.
Nilvadipine
The risk or severity of adverse effects can be increased when Nilvadipine is combined with Nitroglycerin.
Nimodipine
The risk or severity of adverse effects can be increased when Nimodipine is combined with Nitroglycerin.
Nisoldipine
The risk or severity of adverse effects can be increased when Nisoldipine is combined with Nitroglycerin.
Nitrendipine
The risk or severity of adverse effects can be increased when Nitrendipine is combined with Nitroglycerin.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Nitroglycerin.
Nitroprusside
The risk or severity of adverse effects can be increased when Nitroprusside is combined with Nitroglycerin.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Nitroglycerin.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Nitroglycerin.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Nitroglycerin.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Nitroglycerin.
Papaverine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Papaverine.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Nitroglycerin.
Penbutolol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Penbutolol.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Nitroglycerin.
Pentoxifylline
Pentoxifylline may increase the vasodilatory activities of Nitroglycerin.
Pergolide
The bioavailability of Pergolide can be increased when combined with Nitroglycerin.
Perindopril
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Perindopril.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Nitroglycerin.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Nitroglycerin.
Phenoxybenzamine
The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Nitroglycerin.
Phentolamine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Nitroglycerin.
Phentolamine Mesylate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Nitroglycerin.
Pindolol
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Nitroglycerin.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Nitroglycerin.
Prazosin
The risk or severity of adverse effects can be increased when Prazosin is combined with Nitroglycerin.
Prilocaine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Prilocaine.
Primidone
Primidone may increase the hypotensive activities of Nitroglycerin.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Nitroglycerin.
Propranolol
The risk or severity of adverse effects can be increased when Propranolol is combined with Nitroglycerin.
Quetiapine
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Quetiapine.
Quinapril
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Quinapril.
Ramipril
The risk or severity of adverse effects can be increased when Ramipril is combined with Nitroglycerin.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Nitroglycerin.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Nitroglycerin.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Nitroglycerin.
Riociguat
Nitroglycerin may increase the hypotensive activities of Riociguat.
Risperidone
Nitroglycerin may increase the hypotensive activities of Risperidone.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Nitroglycerin.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Nitroglycerin.
Rosiglitazone
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Rosiglitazone.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Nitroglycerin.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Nitroglycerin.
Secobarbital
Secobarbital may increase the hypotensive activities of Nitroglycerin.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Nitroglycerin.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Nitroglycerin.
Sildenafil
Sildenafil may increase the vasodilatory activities of Nitroglycerin.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Nitroglycerin.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Nitroglycerin.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Nitroglycerin.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Nitroglycerin.
Tadalafil
Tadalafil may increase the vasodilatory activities of Nitroglycerin.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Nitroglycerin.
Telmisartan
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Telmisartan.
Terazosin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Terazosin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Nitroglycerin.
Theophylline
Theophylline may increase the vasodilatory activities of Nitroglycerin.
Theophylline anhydrous
Theophylline may increase the vasodilatory activities of Nitroglycerin.
Thiamylal
Thiamylal may increase the hypotensive activities of Nitroglycerin.
Thiopental
Thiopental may increase the hypotensive activities of Nitroglycerin.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Nitroglycerin.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Nitroglycerin.
Timolol
The risk or severity of adverse effects can be increased when Timolol is combined with Nitroglycerin.
Timolol Anhydrous
The risk or severity of adverse effects can be increased when Timolol is combined with Nitroglycerin.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Nitroglycerin.
Tolazoline
The risk or severity of adverse effects can be increased when Tolazoline is combined with Nitroglycerin.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Nitroglycerin.
Torsemide
The risk or severity of adverse effects can be increased when Torasemide is combined with Nitroglycerin.
Trandolapril
The risk or severity of adverse effects can be increased when Trandolapril is combined with Nitroglycerin.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Nitroglycerin.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Nitroglycerin.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Nitroglycerin.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Nitroglycerin.
Vardenafil
Vardenafil may increase the vasodilatory activities of Nitroglycerin.
Verapamil
The risk or severity of adverse effects can be increased when Verapamil is combined with Nitroglycerin.
